Introduction and Overview Neurovascular Devices Market
According to SPER Market Research, the Global Neurovascular Devices Market is estimated to reach USD 9.24 billion by 2034 with a CAGR of 8.95%.
The report includes an in-depth analysis of the Global Neurovascular Devices Market, including market size and trends, product mix, Applications, and supplier analysis. The market for neurovascular devices is expected to reach US$6.02 billion in 2029, having grown from US$3.92 billion in 2024 at a strong compound annual growth rate (CAGR) of 8.95%. Increases in the prevalence of different neurovascular diseases, the growing use of minimally invasive surgical techniques, the development of healthcare infrastructure in developing nations, and strategic alliances and partnerships between manufacturers and research institutions to support the latest advancements in interventional neurology are all factors contributing to this market's growth. Adoption of neurovascular treatment is hampered by the high expense of neurovascular interventional procedures and associated devices, particularly in developing nations with lax reimbursement regulations.
By Device Insights: Cerebral embolization and aneurysm coiling devices had the biggest market share in 2024. Coil embolization is a minimally invasive method for treating aneurysms, where a material closes the aneurysm sac and reduces bleeding risk. A catheter is inserted through the groin and guided to the brain. The growing number of aneurysm cases is likely to boost this segment. These devices include embolic coils, flow diversion devices, and liquid embolic agents. In January 2023, Luidx Medical Technologies, Inc. reported success with the Embolic IMPASS Device for treating chronic subdural hematomas using MMA embolization instead of surgery.
By Therapeutic Application Insights: Stroke held the largest market share in 2024 due to the rising rates of hypertension, stroke, and other neurological disorders. The focus on minimally invasive treatment methods is driving market growth, as these techniques offer shorter recovery times and fewer hospital stays compared to traditional surgeries. Advancements in technology, such as real-time imaging and robotics, enhance the precision and safety of neurovascular interventions, aiding healthcare providers in performing complex procedures. Additionally, the introduction of advanced products further boosts segment growth.
By End Use Insights: Hospital held the largest market share in 2024. This growth is mainly due to the rising number of patients with neurovascular disorders like ischemic and hemorrhagic stroke, brain aneurysm, traumatic brain injury (TBI), and arteriovenous malformation (AVM). More patients are being admitted for surgeries and treatments, which will likely boost market growth. Additionally, the introduction of advanced products and favorable reimbursement policies are key factors driving this segment's growth.
By Regional Insights:
The North American neurovascular devices market dominated the market in 2024 because to the presence of significant manufacturers such as Penumbra, Inc, Stryker Corporation, Johnson & Johnson, and Merit Medical Systems, Inc. in the area. Furthermore, the rising frequency of neurological illnesses and the growing demand for less invasive surgical techniques are propelling market expansion in this area.
Market Competitive Landscape:
Prominent businesses in this neurovascular device sector include reputable, financially secure producers of software, reagents, gel documentation systems, and neurovascular device systems. These businesses have been in the market for a number of years and have advanced technologies, a wide range of products, and robust international sales and marketing networks. In this market, Stryker, Johnson & Johnson, Medtronic plc, Terumo Corporation, and Penumbra, Inc. are notable firms.
Recent Developments:
CERENOVUS, Inc. will debut EMBOGUARD, a next-generation balloon guide catheter, in September 2024 to treat patients with acute ischemic stroke. In May 2024, Penumbra, Inc. declared that Red 78, Red 43, and Red 72 with SENDit Technology, three of its neurovascular reperfusion catheters, had received CE Mark approval and were now accessible in Europe for the treatment of acute ischemic strokes. Terumo Corporation received FDA 510(k) approval in September 2023 for its Sofia EX 5Fr 115cm intracranial support catheter, which is intended for use in trans-radial access. Stryker (US) opened a new research and development center at International Park, Gurgaon, India, in December 2022 with the goal of accelerating advancements in neurovascular devices for the treatment of stroke.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Device, By Therapeutic Application, By End-Use. |
| Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
| Companies Covered | Medtronic, Stryker Corporation, Terumo Corporation, Penumbra, Inc, Johnson & Johnson Services, Inc, Integra LifeSciences Corporation, Acandis GmbH, Spiegelberg GmbH & Co. KG, MicroPort Scientific Corporation, ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO, LTD. |
Key Topics Covered in the Report:
- Global Neurovascular Devices Market Size (FY’2025-FY’2034)
- Overview of Global Neurovascular Devices Market
- Segmentation of Global Neurovascular Devices Market By Device (Cerebral Embolization and Aneurysm Coiling Devices, Cerebral Angioplasty and Stenting Systems, Neurothrombectomy Devices, Support Devices, Trans Radial Access Devices)
- Segmentation of Global Neurovascular Devices Market By Therapeutic Application (Stroke, Cerebral Artery, Cerebral Aneurysm, Others)
- Segmentation of Global Neurovascular Devices Market By End Use (Hospitals, Specialty Clinics, Others)
- Statistical Snap of Global Neurovascular Devices Market
- Expansion Analysis of Global Neurovascular Devices Market
- Problems and Obstacles in Global Neurovascular Devices Market
- Competitive Landscape in the Global Neurovascular Devices Market
- Details on Current Investment in Global Neurovascular Devices Market
- Competitive Analysis of Global Neurovascular Devices Market
- Prominent Players in the Global Neurovascular Devices Market
- SWOT Analysis of Global Neurovascular Devices Market
- Global Neurovascular Devices Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPERs internal database
2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Neurovascular Devices Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Neurovascular Devices Market
7. Global Neurovascular Devices Market, By Device (USD Million) 2021-2034
7.1. Cerebral Embolization and Aneurysm Coiling Devices
7.1.1. Embolic coils
7.1.2. Flow diversion devices
7.1.3. Liquid embolic agents
7.2. Cerebral Angioplasty and Stenting Systems
7.2.1. Carotid artery stents
7.2.2. Embolic protection systems
7.3. Neurothrombectomy Devices
7.3.1. Clot retrieval devices
7.3.2. Suction devices/aspiration catheters
7.3.3. Vascular snares
7.4. Support Devices
7.4.1. Micro catheters
7.4.2. Micro guidewires
7.5. Trans Radial Access Devices
8. Global Neurovascular Devices Market, By Therapeutic Application (USD Million) 2021-2034
8.1. Stroke
8.2. Cerebral Artery
8.3. Cerebral Aneurysm
8.3.1. Aneurysmal Subarachnoid Hemorrhage
8.3.2. Others
8.4. Others
9. Global Neurovascular Devices Market, By End User (USD Million) 2021-2034
9.1. Hospitals
9.2. Specialty Clinics
9.3. Others
10. Global Neurovascular Devices Market Forecast, (USD Million) 2021-2034
10.1. Global Neurovascular Devices Market Size and Market Share
11. Global Neurovascular Devices Market, By Region, 2021-2034 (USD Million)
11.1. Asia-Pacific
11.1.1. Australia
11.1.2. China
11.1.3. India
11.1.4. Japan
11.1.5. South Korea
11.1.6. Rest of Asia-Pacific
11.2. Europe
11.2.1. France
11.2.2. Germany
11.2.3. Italy
11.2.4. Spain
11.2.5. United Kingdom
11.2.6. Rest of Europe
11.3. Middle East and Africa
11.3.1. Kingdom of Saudi Arabia
11.3.2. United Arab Emirates
11.3.3. Qatar
11.3.4. South Africa
11.3.5. Egypt
11.3.6. Morocco
11.3.7. Nigeria
11.3.8. Rest of Middle-East and Africa
11.4. North America
11.4.1. Canada
11.4.2. Mexico
11.4.3. United States
11.5. Latin America
11.5.1. Argentina
11.5.2. Brazil
11.5.3. Rest of Latin America
12. Company Profile
12.1. Medtronic
12.1.1. Company details
12.1.2. Financial outlook
12.1.3. Product summary
12.1.4. Recent developments
12.2. Stryker Corporation
12.2.1. Company details
12.2.2. Financial outlook
12.2.3. Product summary
12.2.4. Recent developments
12.3. Terumo Corporation
12.3.1. Company details
12.3.2. Financial outlook
12.3.3. Product summary
12.3.4. Recent developments
12.4. Penumbra, Inc
12.4.1. Company details
12.4.2. Financial outlook
12.4.3. Product summary
12.4.4. Recent developments
12.5. Johnson & Johnson Services, Inc
12.5.1. Company details
12.5.2. Financial outlook
12.5.3. Product summary
12.5.4. Recent developments
12.6. Integra LifeSciences Corporation
12.6.1. Company details
12.6.2. Financial outlook
12.6.3. Product summary
12.6.4. Recent developments
12.7. Acandis GmbH
12.7.1. Company details
12.7.2. Financial outlook
12.7.3. Product summary
12.7.4. Recent developments
12.8. Spiegelberg GmbH & Co. KG
12.8.1. Company details
12.8.2. Financial outlook
12.8.3. Product summary
12.8.4. Recent developments
12.9. MicroPort Scientific Corporation
12.9.1. Company details
12.9.2. Financial outlook
12.9.3. Product summary
12.9.4. Recent developments
12.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD
12.10.1. Company details
12.10.2. Financial outlook
12.10.3. Product summary
12.10.4. Recent developments
12.11. Others
13. Conclusion
14. List of Abbreviations
15. Reference Links